These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9600579)

  • 1. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G; Arato M
    Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J; Greenberg BD; Murphy DL
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
    Scheepers FE; Gespen de Wied CC; Kahn RS
    J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated.
    Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM
    Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
    Broocks A; Briggs NC; Pigott TA; Hill JL; Canter SK; Tolliver TJ; Baldemore D; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):91-103. PubMed ID: 9106905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
    Mueller EA; Murphy DL; Sunderland T
    Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women.
    Terao T; Nakamura J; Yoshimura R; Ohmori O; Takahashi N; Kojima H; Soeda S; Shinkai T; Nakano H; Okuno T
    Psychiatry Res; 2000 Oct; 96(2):167-73. PubMed ID: 11063789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
    Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
    Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
    Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
    Schwartz PJ; Murphy DL; Wehr TA; Garcia-Borreguero D; Oren DA; Moul DE; Ozaki N; Snelbaker AJ; Rosenthal NE
    Arch Gen Psychiatry; 1997 Apr; 54(4):375-85. PubMed ID: 9107154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T; Riedel WJ; van Praag HM; Menheere PP; Griez E
    Psychiatry Res; 2002 Dec; 113(1-2):29-40. PubMed ID: 12467943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; George A; Jestrabeck C; Opitz M; Bartmann U; Gleiter CH; Meineke I; Roed IS; Rüther E; Hajak G
    Int Clin Psychopharmacol; 2000 May; 15(3):153-61. PubMed ID: 10870873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo.
    Pallanti S; Bernardi S; Quercioli L; DeCaria C; Hollander E
    CNS Spectr; 2006 Dec; 11(12):956-64. PubMed ID: 17146409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
    Nappi RE; Sances G; Brundu B; Ghiotto N; Detaddei S; Biancardi C; Polatti F; Nappi G
    Neuroendocrinology; 2003 Jul; 78(1):52-60. PubMed ID: 12869800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects.
    George DT; Benkelfat C; Rawlings RR; Eckardt MJ; Phillips MJ; Nutt DJ; Wynne D; Murphy DL; Linnoila M
    Am J Psychiatry; 1997 Jan; 154(1):81-7. PubMed ID: 8988963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats.
    Mazzola-Pomietto P; Aulakh CS; Murphy DL
    Eur J Pharmacol; 1996 Jul; 308(3):329-33. PubMed ID: 8858308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.